SAB Biotherapeutics, Inc. (SABSW) stock
SABSWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as SABS
$0.01+0.00 (+33.33%)
Close on Oct 20, 2026Market cap $304.80MP/E –Yield –
SAB Biotherapeutics statistics
58 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Oct 30, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 1.42
- 2.47
Share statisticsIndustry
- Shares Change (QoQ)
- 10.2%
- 0.54%
- Float
- 63M
- 49M
- Shares Held by Insiders
- 30.2%
- 11.4%
- Shares Held by Institutions
- 76.1%
- 56.1%
Short sellingIndustry
- Short Interest
- 4M
- –
- Short Interest Change
- 19.1%
- 0.60%
- Days to Cover
- 4.99
- 4.58
Stock price statisticsIndustry
- 52-Week High
- $5.15
- –
- 52-Week Low
- $2.44
- –
- 20-Day Moving Average
- $2.89
- –
- 50-Day Moving Average
- $3.26
- –
- 200-Day Moving Average
- $3.68
- –
- Average True Range (14)
- $0.22
- –
- Price Change (1 Week)
- 18.0%
- 1.30%
- Price Change (1 Month)
- 9.48%
- -7.60%
- Price Change (3 Months)
- -11.6%
- -14.4%
- Price Change (6 Months)
- -3.46%
- -19.7%
- Price Change (YTD)
- -10.4%
- -19.6%
- Price Change (1 Year)
- 10.2%
- -21.9%
- Price Change (3 Years)
- -66.5%
- -22.6%
- Price Change (5 Years)
- -95.8%
- -75.5%
- Average Volume (10 Days)
- 604,988
- –
- Average Volume (20 Days)
- 685,360
- –
- Average Volume (90 Days)
- 586,326
- –
- Relative Volume
- 1.27
- 0.73
- Relative Strength Index (14)
- 60.2
- 44.2
- Volatility (1 Year)
- 61.4%
- 79.5%
- Beta (5 Years)
- 1.41
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- -11.3%
- -53.1%
- Return on Assets (ROA)
- -9.52%
- -40.9%
- Return on Invested Capital (ROIC)
- -95.8%
- -33.0%
- Return on Capital Employed (ROCE)
- -31.7%
- -38.6%
Financial positionIndustry
- Current Ratio
- 9.22
- 3.30
- Quick Ratio
- 8.77
- 2.39
- Interest Coverage
- -310.26
- -6.26
EfficiencyIndustry
- Profits Per Employee
- -$148.55K
- -$705.27K
- Employee Count
- 86
- 75
- WACC
- 12.0%
- 10.1%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $102.63M
- $15.31M
- Net Cash Per Share
- $1.13
- $0.66
- Equity (Book Value)
- $214.79M
- $48.79M
- Book Value Per Share
- $2.36
- $1.36
- Tangible Book Value
- $214.79M
- $23.91M
- Working Capital
- $96.23M
- $74.41M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- -4.19%
- -20.7%
Taxes and interestIndustry
- Interest Expense
- $231.50K
- $3.07M
Scores and fair valueIndustry
- Altman Z-Score
- 6.40
- 0.25
- Piotroski F-Score
- 4
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 20, 2026. The S&P 500 is measured by the SPY fund.
| Period | SABSW | S&P 500 | Difference | SABSW per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -28.6% | +1.0% | −29.5 pts | ||
| 3 months | -42.2% | +3.9% | −46.1 pts | ||
| Year to date | -67.9% | +13.7% | −81.6 pts | ||
| 1 year | -66.2% | +15.8% | −82.0 pts | ||
| 3 years | -87.5% | +89.3% | −176.8 pts | -50.0% | +23.7% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 15, 2026.
0M SABSW shares were sold short on Oct 15, 2026, up 78.0% from the previous report. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 23.4% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 15, 2026 | 1,344 | +78.0% | 53,601 | 1.0 |
| Sep 30, 2026 | 755 | -1.3% | 15,169 | 1.0 |
| Sep 15, 2026 | 765 | -88.5% | 43,794 | 1.0 |
| Aug 31, 2026 | 6,640 | -78.9% | 300,155 | 1.0 |
| Aug 14, 2026 | 31,402 | +407.1% | 52,642 | 1.0 |
| Jul 31, 2026 | 6,193 | -35.0% | 82,098 | 1.0 |
| Jul 15, 2026 | 9,524 | +1461.3% | 264,901 | 1.0 |
| Jun 30, 2026 | 610 | -91.1% | 7,586 | 1.0 |
| Jun 15, 2026 | 6,872 | +117.6% | 38,353 | 1.0 |
| May 29, 2026 | 3,158 | -30.3% | 7,462 | 1.0 |
| May 15, 2026 | 4,533 | +1237.2% | 32,028 | 1.0 |
| Apr 30, 2026 | 339 | -73.4% | 7,336 | 1.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.